{{Rsnum
|rsid=680379
|Chromosome=20
|position=12988752
|Orientation=plus
|GMAF=0.3329
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.5 | 57.1 | 30.4
| HCB | 16.9 | 45.6 | 37.5
| JPT | 19.5 | 51.3 | 29.2
| YRI | 2.7 | 19.0 | 78.2
| ASW | 0.0 | 29.8 | 70.2
| CHB | 16.9 | 45.6 | 37.5
| CHD | 13.9 | 49.1 | 37.0
| GIH | 4.0 | 39.6 | 56.4
| LWK | 0.9 | 33.6 | 65.5
| MEX | 13.8 | 51.7 | 34.5
| MKK | 6.4 | 30.8 | 62.8
| TSI | 13.7 | 38.2 | 48.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19798445
|Trait=Sphingolipid Concentrations
|Title=Genetic determinants of circulating sphingolipid concentrations in European populations
|RiskAllele=A
|Pval=8E-15
|OR=0.10
|ORtxt=[0.08-0.13] mol % increase
|OA=1
}}

{{PMID Auto GWAS
|PMID=22359512
|Trait=None
|Title=Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.
|RiskAllele=
|Pval=2E-16
|OR=0
|ORtxt=None
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs680379
|overall_frequency_n=91
|overall_frequency_d=128
|overall_frequency=0.710938
|n_genomes=48
|n_genomes_annotated=0
|n_haplomes=76
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}